| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | -0.3 | 6e-06 |
| mRNA | Topotecan | CCLE | pan-cancer | AAC | -0.19 | 0.0003 |
| mRNA | PD-0325901 | CCLE | pan-cancer | AAC | 0.18 | 0.0005 |
| mRNA | PLX4720 | CCLE | pan-cancer | AAC | 0.17 | 0.002 |
| mRNA | Panobinostat | CCLE | pan-cancer | AAC | -0.14 | 0.005 |
| mRNA | AZD6244 | CCLE | pan-cancer | AAC | 0.14 | 0.007 |
| mRNA | TAE684 | CCLE | pan-cancer | AAC | 0.14 | 0.01 |
| mRNA | paclitaxel | CCLE | pan-cancer | AAC | -0.13 | 0.02 |
| mRNA | 17-AAG | CCLE | pan-cancer | AAC | 0.13 | 0.03 |
| mRNA | Crizotinib | CCLE | pan-cancer | AAC | 0.097 | 0.09 |